Silicon Valley VC backs Raleigh startup with ties to Joe DeSimone that’s targeting pancreatic cancer
A Raleigh life science startup targeting pancreatic cancer and other diseases with what it calls a “novel” drug delivery system developed at UNC-Chapel Hill, has $5.5 million in new capital to fund further research in a round led by Silicon Valley venture capital firm Khosla Ventures.
Read More
